The Role of the Private Sector in the European Market

Published by	HBS Consulting
Published	June, 2006	Product code	40488
Content info
Price	US $ 4450 MS Word file by E-mail (Single User License) US $ 4450 PDF by E-mail (Single User License) US $ 4500 Hard Copy

Introduction
Related Reports

The Role of the Private Sector in the European Market published by HBS Consulting in June, 2006. This report price starts from US $ 4450.

Introduction

Abstract

This latest strategic publication from HBS Consulting provides an overview of the changes taking place in the European private healthcare sector which will have a bearing on development of business and marketing strategies of medical devices and diagnostic manufactures. The report,

examines the trends in private healthcare provision and financing in key EU markets. Additionally, the two largest of the new EU member states - Hungary and Poland - are included
provides an overview of the main corporate players in the respective European markets
highlights some of the challenges and opportunities for manufacturers of medical devices and diagnostics in the emerging private healthcare sector
assesses some of the lessons which might be learned from studying the US model for healthcare provision

1 EXECUTIVE SUMMARY

2 INTRODUCTION

2.1 Models of Healthcare Systems in Europe
- 2.1.1 Role of Private Medical Insurance
- 2.1.2 Role of Private Providers
  - 2.1.2.1 Leading Providers
2.2 The Funding Conundrum
- 2.2.1 The Dutch Model
2.3 Escalating Costs of Healthcare Services and Technology
2.4 Private Medical Insurance Increasing
2.5 Role of MedTech/Healthcare Companies in Healthcare Provision

3 THE PRIVATE SECTOR'S ROLE IN KEY EU MARKETS

3.1 FRANCE
- 3.1.1 French Health System and the Private Sector
- 3.1.2 Private Providers
- 3.1.3 Private Medical Insurance
- 3.1.4 Market Dynamics
3.2 GERMANY
- 3.2.1 German Health System & the Private Sector
- 3.2.2 Private Providers
- 3.2.3 Private Medical Insurance
- 3.2.4 Market Dynamics
3.3 ITALY
- 3.3.1 Italian Health System and the Private Sector
- 3.3.2 Private Providers
- 3.3.3 Private Medical Insurance
- 3.3.4 Market Dynamics
3.4 SPAIN
- 3.4.1 Spanish Health System & the Private Sector
- 3.4.2 Private Providers
- 3.4.3 Private Medical Insurance
- 3.4.4 Market Dynamics
3.5 UK
- 3.5.1 UK Health System and the Private Sector
- 3.5.2 Private Providers
- 3.5.3 Private Medical Insurance
- 3.5.4 Market Dynamics
3.6 Focus on Major New EU Markets
- 3.6.1 HUNGARY
  - 3.6.1.1 Hungarian Health System and the Private Sector
  - 3.6.1.2 Private Providers
  - 3.6.1.3 Private Medical Insurance
  - 3.6.1.4 Market Dynamics
- 3.6.2 POLAND
  - 3.6.2.1 Polish Health System and the Private Sector
  - 3.6.2.2 Private Providers
  - 3.6.2.3 Private Medical Insurance
  - 3.6.2.4 Market Dynamics

4 MEDTECH PURCHASING BY PRIVATE PURCHASERS

4.1 Key Decision-Makers
4.2 Factors Influencing Purchasing Decisions
4.3 Purchasing Mechanisms
4.4 Group Purchasing
- 4.4.1 The German Experience
4.5 Sales & Marketing Strategies
4.6 Leasing

5 THE US MODEL: LESSONS FOR EUROPE

5.1 US Healthcare System
- 5.1.2 Sources of Healthcare Funding
- 5.1.3 Private Healthcare Insurance
  - 5.1.3.1 Managed Care
  - 5.1.3.2 Trends in Employer-Sponsored Health Insurance
  - 5.1.3.3 Individual Health Insurance
- 5.1.4 Universal Access Remains Elusive
5.2 The US vs Europe: Impact on MedTech
5.3 Learning from the US Model
- 5.3.1 GPOs: The US Experience
  - 5.3.1.1 GPOs: Lessons for Europe
- 5.3.2 Managed Care
  - 5.3.2.1 The UK Experience
    - 5.3.2.1.1 The Kaiser Model
    - 5.3.2.1.2 The Evercare Programme
- 5.3.3 Health Technology Assessment
  - 5.3.3.1 Key Lessons